{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:28:50Z","timestamp":1785252530264,"version":"3.55.0"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>This study aimed to evaluate the effectiveness of intravenous versus oral antibiotic treatments in managing bone infections, particularly osteomyelitis, using a rat tibial infection model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A tibial bone infection model was established in twelve-week-old Wistar rats via injection of <jats:italic>Staphylococcus aureus<\/jats:italic> at a cortical defect site. After six weeks, rats were treated with vancomycin (intravenous), cefazolin (intravenous), ciprofloxacin (oral), or ciprofloxacin combined with rifampin (oral). Microbial analysis, blood analysis for pro-inflammatory cytokines, micro-computed tomography (\u03bcCT), histological analysis, and osteoclast activity were used to assess the efficacy of each treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Blood analysis showed significant reductions in white blood cell count and pro-inflammatory cytokines in the intravenous treatment groups, especially with vancomycin. \u03bcCT imaging revealed better preservation of bone structure in intravenous treatment groups, while oral treatments resulted in more pronounced structural deterioration. Microbial analysis confirmed a lower bacterial load in the intravenous groups, particularly vancomycin, compared to oral treatments. Histological analysis revealed reduced inflammation, lower fibrosis, and minimal bacterial presence in intravenous groups. Osteoclast activity was notably reduced in the vancomycin and cefazolin groups, indicating better control of bone resorption.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Intravenous administration of vancomycin demonstrated superior efficacy in controlling bone infection, reducing inflammation, and preserving bone structure compared to oral treatments. While ciprofloxacin and the ciprofloxacin-rifampin combination showed some efficacy, they were less effective than intravenous vancomycin, likely due to lower bioavailability and insufficient drug penetration in bone tissue.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2025.1529692","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T14:09:40Z","timestamp":1740751780000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparative study of the inhibitory effects of different antibiotic administration routes on bone healing in a rat tibial infection model"],"prefix":"10.3389","volume":"15","author":[{"given":"Xiaoyu","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengli","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisong","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaofeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang","family":"Kai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00153-23","article-title":"Efficacy of ceftaroline and rifampin, alone or combined, in a rat model of methicillin-resistant Staphylococcus epidermidis osteomyelitis without implant","volume":"11","author":"Albac","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"B2","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1002\/art.42074","article-title":"Role of lysine-specific demethylase 1 in metabolically integrating osteoclast differentiation and inflammatory bone resorption through hypoxia-inducible factor 1\u03b1 and E2F1","volume":"74","author":"Doi","year":"2022","journal-title":"Arthritis Rheumatol. (Hoboken N.J.)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.bone.2013.04.018","article-title":"Local gentamicin application does not interfere with bone healing in a rat model","volume":"55","author":"Fassbender","year":"2013","journal-title":"Bone"},{"key":"B4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2165\/00003088-200948020-00002","article-title":"Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations","volume":"48","author":"Landersdorfer","year":"2009","journal-title":"Clin. Pharmacokinet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0140-6736(04)16727-5","article-title":"Osteomyelitis","volume":"364","author":"Lew","year":"2004","journal-title":"Lancet (London England)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1056\/NEJMoa1710926","article-title":"Oral versus intravenous antibiotics for bone and joint infection","volume":"380","author":"Li","year":"2019","journal-title":"New Engl. J. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41579-022-00686-0","article-title":"Skeletal infections: microbial pathogenesis, immunity and clinical management","volume":"20","author":"Masters","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s11914-019-00548-4","article-title":"Mechanisms of immune evasion and bone tissue colonization that make Staphylococcus aureus the primary pathogen in osteomyelitis","volume":"17","author":"Muthukrishnan","year":"2019","journal-title":"Curr. Osteoporosis Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1749-799X-8-38","article-title":"A rabbit osteomyelitis model for the longitudinal assessment of early post-operative implant infections","volume":"8","author":"Odekerken","year":"2013","journal-title":"J. Orthopaedic Surg. Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/0002-9343(91)90181-V","article-title":"Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics","volume":"91","author":"Paladino","year":"1991","journal-title":"Am. J. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.cmi.2023.05.008","article-title":"Early switch from intravenous to oral antibiotic treatment in bone and joint infections","volume":"29","author":"Sendi","year":"2023","journal-title":"Clin. Microbiol. Infection"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1002\/jorr.v36.12","article-title":"Topical rifampin powder for orthopaedic trauma part II: Topical rifampin allows for spontaneous bone healing in sterile and contaminated wounds","volume":"36","author":"Shiels","year":"2018","journal-title":"J. Orthopaedic Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/cid\/cir842","article-title":"Systemic antibiotic therapy for chronic osteomyelitis in adults","volume":"54","author":"Spellberg","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S1473-3099(01)00094-9","article-title":"Systematic review and meta-analysis of antibiotic therapy for bone and joint infections","volume":"1","author":"Stengel","year":"2001","journal-title":"Lancet Infect. Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijid.2019.02.005","article-title":"Antibiotic penetration into bone and joints: An updated review","volume":"81","author":"Thabit","year":"2019","journal-title":"Int. J. Infect. Diseases: IJID"},{"key":"B16","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.jinf.2014.12.016","article-title":"Comparative activities of vancomycin, tigecycline and rifampin in a rat model of methicillin-resistant Staphylococcus aureus osteomyelitis","volume":"70","author":"Vergidis","year":"2015","journal-title":"J. Infection"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.7150\/ijms.45960","article-title":"The process of osteoblastic infection by Staphylococcus aureus","volume":"17","author":"Wen","year":"2020","journal-title":"Int. J. Med. Sci."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00415-18","article-title":"Novel Insights into Staphylococcus aureus Deep Bone Infections: the Involvement of Osteocytes","volume":"9","author":"Yang","year":"2018","journal-title":"mBio"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.583561","article-title":"Intrinsic restriction of TNF-mediated inflammatory osteoclastogenesis and bone resorption","volume":"11","author":"Zhao","year":"2020","journal-title":"Front. Endocrinol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1001\/jama.279.19.1537","article-title":"Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group","volume":"279","author":"Zimmerli","year":"1998","journal-title":"Jama"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1529692\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T14:09:42Z","timestamp":1740751782000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1529692\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":20,"alternative-id":["10.3389\/fcimb.2025.1529692"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1529692","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"article-number":"1529692"}}